stockrowRadNet, Inc.
RDNT Healthcare Diagnostics & Research
RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.
- Revenue
- +25.0%
- EPS
- −47.4%
- Free cash flow
- −43.2%
- Total debt
- +21.2%
Quarter to June 2026, against a year earlier
Follow RDNT
Alert me
RadNet, Inc. (RDNT) Current ratio
RadNet, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 1.5×, down 0.3× from fiscal 2025 (1.8×). Over the past ten years it has ranged from 0.7× (fiscal 2020) to 2.1× (fiscal 2024); the current reading is higher than 91% of that period. That is below the Diagnostics & Research industry median of 2.3× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.8× | (17.21%) |
| FY2024 | 2.1× | 60.45% |
| FY2023 | 1.3× | 68.32% |
| FY2022 | 0.8× | (9.07%) |
| FY2021 | 0.9× | 27.37% |
| FY2020 | 0.7× | (7.78%) |
| FY2019 | 0.7× | (15.46%) |
| FY2018 | 0.9× | (29.06%) |
| FY2017 | 1.2× | (12.44%) |
| FY2016 | 1.4× | (4.00%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 1.5× | 27.36% |
| Mar 2026 | 1.2× | (33.75%) |
| Dec 2025 | 1.8× | (6.17%) |
| Sep 2025 | 1.9× | (6.43%) |
| 42 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| BLLN BillionToOne, Inc. compare | 11.2× |
| GRAL GRAIL, Inc. compare | 8.9× |
| VCYT Veracyte, Inc. compare | 5.6× |
| ADPT Adaptive Biotechnologies Corporation compare | 4.0× |
| SHC Sotera Health Company compare | 3.1× |
| QGEN QIAGEN N.V. compare | 2.8× |
| CDNA CareDx, Inc. compare | 2.3× |
| RDNT RadNet, Inc. | 1.5× |
| ICLR ICON PLC compare | 1.3× |
| Diagnostics & Research industry median | 2.3× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on RDNT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement